You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposomal doxorubicin

Showing 51 - 75 of 2,209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Adult Soft Tissue Sarcoma Trial in Shanghai (Pegylated liposomal doxorubicin, Anlotinib)

Recruiting
  • Stage III Adult Soft Tissue Sarcoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 18, 2021

Breast Cancer, HER2-positive Breast Cancer Trial in Xi'an (pegylated liposomal doxorubicin (PLD) plus cyclophosphamide followed

Recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • pegylated liposomal doxorubicin (PLD) plus cyclophosphamide followed by Nab-paclitaxel (Nab-P) ,continuously combined with dual HER2 blockage
  • Xi'an, Shaanxi, China
    Xijing Hospital ， Fourth Military Medical University
Apr 23, 2022

Ovarian Cancer Trial in Switzerland, United States (Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod)

Completed
Has Results
  • Ovarian Cancer
  • Phoenix, Arizona
  • +4 more
Aug 9, 2021

High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

Completed
Has Results
  • High-grade Serous Ovarian Cancer
  • APR-246
  • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
  • Gent, Belgium
  • +11 more
Jul 19, 2022

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • +4 more
  • Birmingham, Alabama
  • +15 more
Dec 13, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

Recruiting
  • Ovarian Cancer
  • +3 more
  • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
  • Blacktown, New South Wales, Australia
  • +5 more
Nov 9, 2022

Ovarian Cancer Trial in United States (AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +15 more
Feb 16, 2022

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)

Recruiting
  • Multiple Myeloma
  • Selinexor (80mg/d)
  • +4 more
  • Zhengzhou, Henan, China
  • +4 more
Aug 16, 2022

Ovarian Tumors Malignant (Excl Germ Cell), Peritoneal Carcinoma, Fallopian Tube Cancer Trial (trientine diHCl, pegylated

Completed
Has Results
  • Ovarian Neoplasms Malignant (Excl Germ Cell)
  • +2 more
  • trientine dihydrochloride
  • +2 more
  • (no location specified)
Oct 18, 2020

Ovarian Cancer Trial in Spain (Olaparib)

Active, not recruiting
  • Ovarian Cancer
  • Badalona, Spain
  • +15 more
Aug 4, 2021

Ovarian Epithelial Cancer Trial in Leuven (Olaparib, carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin +

Active, not recruiting
  • Ovarian Epithelial Cancer
  • Olaparib
  • carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly
  • Leuven, Belgium
    UZLeuven
Jan 26, 2021

Ovarian Tumors Trial in Rome (Trabectedin, Pegylated Liposomal Doxorubicin, Topotecan)

Completed
  • Ovarian Neoplasms
  • Rome, Italy
    Domenica Lorusso
Aug 24, 2021

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Metastatic Breast Cancer Trial in Jerusalem (Chemotherapy Drugs, Cancer)

Recruiting
  • Metastatic Breast Cancer
  • Chemotherapy Drugs, Cancer
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Oct 22, 2020

HER2-positive Breast Cancer Trial in Beijing (pegylated liposomal doxorubicin)

Unknown status
  • HER2-positive Breast Cancer
  • pegylated liposomal doxorubicin
  • Beijing, Beijing, China
    Peng Yuan
Jul 7, 2020

Recurrent, Platinum-resistant Ovarian Cancer Trial in Milan (Decitabine, Carboplatin, Pegylated Liposomal Doxorubicin)

Recruiting
  • Recurrent, Platinum-resistant Ovarian Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Lymphoma Trial in United States (Filgrastim, Pegfilgrastim, Rituximab)

Completed
Has Results
  • Lymphoma
  • Filgrastim
  • +6 more
  • Fort Smith, Arkansas
  • +6 more
Sep 22, 2020

Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or

Completed
  • Breast Cancer
    • Tianjin, China
      Jin Zhang
    Jul 5, 2020

    Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • +2 more
    • Nemvaleukin and Pembrolizumab Combination
    • +6 more
    • Ventura, California
    • +7 more
    Aug 5, 2022

    Metastatic Breast Cancer, Breast Cancer, Breast Tumors Trial in Utrecht (LTLD, MR-HIFU induced hyperthermia, Cyclophosphamide)

    Recruiting
    • Metastatic Breast Cancer
    • +7 more
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Feb 16, 2021

    Platinum-Sensitive Ovarian Cancer in First Relapse Trial in Worldwide (Farletuzumab, Placebo)

    Completed
    Has Results
    • Platinum-Sensitive Ovarian Cancer in First Relapse
    • Phoenix, Arizona
    • +67 more
    Aug 9, 2021

    Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)

    Withdrawn
    • Progression-free Survival
    • +2 more
    • Beijing, China
      Peking University People's Hospital
    May 15, 2020

    Ovarian Cancer Trial in Italy (Niraparib, Dostarlimab, Pegylated liposomal doxorubicin)

    Recruiting
    • Ovarian Cancer
    • Brescia, Italy
    • +7 more
    Aug 24, 2021